Psychedelics Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products April 20, 2026
Psychedelics Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public Offering March 16, 2026
Psychedelics Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness October 28, 2022
Search
Psychedelics
